Similar articles

• Short-term rifampicin pretreatment reduces inflammation and neuronal cell death in a rabbit model of bacterial meningitis.

  Spreer A, Lugert R, Stoltefaut V, Hoecht A, Eiffert H, Nau R. Spreer A, et al. Crit Care Med. 2009 Jul;37(7):2253-8. doi: 10.1097/CCM.0b013e3181a036c0. Crit Care Med. 2009. PMID: 19487938
• Early vancomycin therapy and adverse outcomes in children with pneumococcal meningitis.

  Buckingham SC, McCullers JA, Luján-Zilbermann J, Knapp KM, Orman KL, English BK. Buckingham SC, et al. Pediatrics. 2006 May;117(5):1688-94. doi: 10.1542/peds.2005-2282. Pediatrics. 2006. PMID: 16651325
• Rifampicin+ceftriaxone versus vancomycin+ceftriaxone in the treatment of penicillin- and cephalosporin-resistant pneumococcal meningitis in an experimental rabbit model.

  Suntur BM, Yurtseven T, Sipahi OR, Buke C, Buke M. Suntur BM, et al. Int J Antimicrob Agents. 2005 Sep;26(3):258-60. doi: 10.1016/j.ijantimicag.2005.06.010. Int J Antimicrob Agents. 2005. PMID: 16099624
• [Treatment of purulent meningitis].

  Skinhøj P, Jacobsen E, Høiby N. Skinhøj P, et al. Ugeskr Laeger. 1991 Sep 23;153(39):2728-30. Ugeskr Laeger. 1991. PMID: 1949282 Review. Danish.
• Antimicrobial therapy in pneumococcal meningitis: an epidemiological assessment from Turkey.

  Erdem H, Pahsa A, Oncu S. Erdem H, et al. Int J Infect Dis. 2006 May;10(3):262-3. doi: 10.1016/j.ijid.2005.03.009. Epub 2006 Jan 10. Int J Infect Dis. 2006. PMID: 16412676 Review. No abstract available.